best performing mid-cap stocks in august 2026

Abcellera Biologics  (ABCL) had the highest return in August 2026 by a mid-cap US stock, returning 101.2%.

ASSETMONTH% RETURN
Abcellera Biologics  (ABCL)
August 2026
101.23%
Iovance Biotherapeutics (IOVA)
August 2026
99.27%
Heartflow, Inc Common Stock (HTFL)
August 2026
94.41%
Hyperliquid Strategies Inc Common Stock (PURR)
August 2026
93.22%
Twist Bioscience (TWST)
August 2026
70.34%
NIQ Global Intelligence (NIQ)
August 2026
67.49%
Amylyx Pharmaceuticals (AMLX)
August 2026
66.34%
Accelerant (ARX)
August 2026
63.6%
Caris Life Sciences, Inc Common Stock (CAI)
August 2026
60.11%
Wix (WIX)
August 2026
59.3%
Bullish (BLSH)
August 2026
58.13%
Appian (APPN)
August 2026
54.16%
Amplitude (AMPL)
August 2026
53.93%
Aura Minerals Inc Common Shares (AUGO)
August 2026
53.65%
NovaGold (NG)
August 2026
48.28%
SSR Mining (SSRM)
August 2026
48.27%
Figure Technology Solutions, Inc Class A Common Stock (FIGR)
August 2026
47.5%
Eldorado Gold (EGO)
August 2026
47.11%
Elastic (ESTC)
August 2026
45.58%
B2Gold (BTG)
August 2026
45.36%
Tempus AI, Inc Class A Common Stock (TEM)
August 2026
45.14%
Perrigo (PRGO)
August 2026
44.92%
IAMGold (IAG)
August 2026
44.73%
Twenty One Capital (XXI)
August 2026
43.66%
Fortuna Silver Mines (FSM)
August 2026
43.47%
Mid-cap stocks are treated as having a market cap between $2B and $10B.